Product Information
CYCLOBENZAPRINE 5 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0211 per EA under NDC 72888001200. Its NADAC has been published 196 times since Sep 28, 2022.
Strength
5 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888001200
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208170On Market Since
5/31/2017
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 5 MG TABLET has been published 196 times since Sep 28, 2022, and over the history we have for it it has declined 16.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0211 per EA |
|---|---|
| All-time high | $0.0284 (Nov 16, 2022) |
| All-time low | $0.0157 (Nov 20, 2024) |
| 52-week high | $0.0220 |
| 52-week low | $0.0209 |
| Median price | $0.0220 |
| Average price | $0.0220 |
| Largest weekly change | +36.3% (Aug 21, 2024) |
| Weeks tracked | 196 |
| Tracking since | Sep 28, 2022 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 5 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.0211 per EA (NDC 72888001200), effective Jun 24, 2026.
How has the price of CYCLOBENZAPRINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has declined 16.0%. It has been tracked across 196 weekly CMS publications since Sep 28, 2022.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 5 MG TABLET?
Since Sep 28, 2022, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has ranged from a low of $0.0157 (Nov 20, 2024) to a high of $0.0284 (Nov 16, 2022), with a median of $0.0220 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 5 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CYCLOBENZAPRINE 5 MG TABLET, but none are currently priced below it.
Who manufactures CYCLOBENZAPRINE 5 MG TABLET?
CYCLOBENZAPRINE 5 MG TABLET (NDC 72888001200) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification